早期百白破疫苗接种与女性死亡率关系的再检验:一项随机试验内的观察性研究
在几内亚比绍的低体重新生儿中,2,398名婴儿随机接受早期或延迟卡介苗,并于2、6、12月龄随访。2月龄时75%已接种百白破疫苗;2至6月龄间共29例死亡。早期百白破与未接种相比,调整后女性死亡风险比为1.19(95%CI 0.45-3.15),未发现女性死亡率增加。
要点
- 早期百白破疫苗接种与女性死亡率增加无显著关联。
- 女性调整后死亡风险比为1.19(95%CI 0.45-3.15)。
- 结果差异可能与总死亡率下降和疫苗接种实践变化有关。
核心结论
- 未发现早期百白破疫苗接种与女性死亡率增加存在关联,与既往研究结果不同。
研究设计与样本
- 在几内亚比绍开展的低体重新生儿随机试验内进行观察性分析,2,398名婴儿随机接受早期或延迟卡介苗,于2、6、12月龄随访。
主要发现
- 2月龄时75%(1,795/2,398)已接种百白破疫苗,接种者出生时和2月龄时人体测量学指标优于未接种者。
- 2至6月龄间共发生29例死亡,早期百白破与未接种相比调整后死亡风险比为1.09(95%CI 0.44-2.69)。
- 女性调整后死亡风险比为1.19(95%CI 0.45-3.15),男性为0.77(95%CI 0.14-4.19)。
- 与既往研究相比,本研究队列总死亡率降低56%(30-72%),未接种百白破婴儿更少,卡介苗覆盖率更高,且开展了更多口服脊灰疫苗运动。
临床怎么用
- 在评估百白破疫苗非特异性效应时,需考虑总死亡率水平和疫苗接种实践变化的影响。
局限性
- 本研究为观察性分析,可能存在混杂;死亡例数较少,置信区间较宽;结果可能与既往研究存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are worrying indications that diphtheria-tetanus-pertussis (DTP) vaccine has negative non-specific effects for females. We previously found, in a trial of early-Bacillus Calmette-Guérin (BCG) to low weight (LW) neonates, that receiving early-DTP (before 2 months of age), was associated with increased female mortality compared with no-DTP/delayed-DTP. Within a subsequent LW trial, we aimed to retest this observation. METHODS: Between 2010 and 2014, in Guinea-Bissau, 2,398 infants were randomised 1:1 to early-BCG (intervention) or delayed-BCG (standard practice for LW neonates) and visited at 2, 6 and 12 months of age to assess nutritional and vaccination status. DTP is recommended at 6 weeks of age. We examined the effect of having "early-DTP" versus "no-DTP" at the time of the 2-month visit on all-cause mortality between the 2- and 6-month visits in Cox models stratified by sex and adjusted for BCG-group and 2-month-weight-for-age (z-scores) providing adjusted mortality rate ratios (aMRRs). We analysed to which extent conditions varied between the present and the previous LW trials and how that might have affected the overall result of comparing the early-DTP and the no-DTP groups. RESULTS: At the time of the 2-month visit, 75% (1,795/2,398) had received DTP. Those vaccinated had better anthropometric indices than no-DTP infants at birth and by 2 months of age. Between the 2- and 6-month visits, 29 deaths occurred. The early-DTP/no-DTP aMRR was 1.09 (95% CI: 0.44-2.69); 1.19 (0.45-3.15) for females and 0.77 (0.14-4.19) for males. Compared to the previous study, the present study cohort had 56% (30-72%) lower overall mortality, fewer no-DTP infants, higher BCG vaccination coverage and several more oral polio vaccine campaigns. CONCLUSION: We did not find that early-DTP was associated with increased female mortality as found in a previous study; differences in results may partly be due to a decline in overall mortality and changes in vaccination practices.
引用
- Sørensen MK, Schaltz-Buchholzer F, Jensen AM, et al. Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial. Vaccine. 2021. PMID: 34217570. doi:10.1016/j.vaccine.2021.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。